Home
>
National Drug Code (NDC)
>
Captopril and Hydrochlorothiazide
Captopril and Hydrochlorothiazide - 0093-0181-01 - (Captopril and Hydrochlorothiazide)
Drug Information of Captopril and Hydrochlorothiazide
| Product NDC: | 0093-0181 |
| Proprietary Name: | Captopril and Hydrochlorothiazide |
| Non Proprietary Name: | Captopril and Hydrochlorothiazide |
| Active Ingredient(s): | 50; 15 mg/1; mg/1 & nbsp; Captopril and Hydrochlorothiazide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Captopril and Hydrochlorothiazide
| Product NDC: | 0093-0181 |
| Labeler Name: | Teva Pharmaceuticals USA Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074827 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19971230 |
Package Information of Captopril and Hydrochlorothiazide
| Package NDC: | 0093-0181-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (0093-0181-01) |
NDC Information of Captopril and Hydrochlorothiazide
| NDC Code | 0093-0181-01 |
| Proprietary Name | Captopril and Hydrochlorothiazide |
| Package Description | 100 TABLET in 1 BOTTLE (0093-0181-01) |
| Product NDC | 0093-0181 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Captopril and Hydrochlorothiazide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19971230 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Pharmaceuticals USA Inc |
| Substance Name | CAPTOPRIL; HYDROCHLOROTHIAZIDE |
| Strength Number | 50; 15 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
